Study on Prophylactic Therapy for Esophago-gastric Varices in Patients with Hepatocellular Carcinoma
スポンサーリンク
概要
- 論文の詳細を見る
We evaluated effect of prophylactic treatment on esophageal varices in 126 patients with hepatocellular carcinoma (HCC). A cumulative bleeding rate and a death rate were compared between 54 patients who underwent prophylactic therapy (prophylactic group) and 72 patients who did not undergo the treatment (non-prophylactic group). Cumulative bleeding rate in the prophylactic group was significantly lower than that in the non-prophylactic group (5.6% vs 23.5%, p <0.001). Death rate due to variceal bleeding and hepatic failure following variceal bleeding was significantly lower in the prophylactic group than in the non-prophylactic group (1 case, 2.9% vs 10 cases, 16.1%, p <0.05). A cumulative survival rate in the prophylactic group was significantly higher than that in the non-prophylactic group (p <0.0001). Nine patients with tumor thrombus in the main portal vein (Vp<SUB>3</SUB>) had an extremely poor prognosis (survival periods of 66.7 days on average) and there was no statistical difference in the survival period between the cases of bleeding from esophageal varices and of non-bleeding. We conclude that prophylactic therapy for esophago-gastric varices in patients with HCC is valuable, because it decreases the rate of bleeding from esophageal varices and death caused by the bleeding, resulting in a prolonged survival period. The usefulness of prophylactic therapy for Vp<SUB>3</SUB> cases is, however, limited at present.
- The Japan Society for Portal Hypertensionの論文
The Japan Society for Portal Hypertension | 論文
- 経食道アプローチによる超音波検査法が診断に有用であったBudd-Chiari症候群の1例
- 内視鏡的治療後の遺残再発静脈瘤に対するHassab手術成績の検討
- 肝過形成結節を伴った先天性門脈欠損症の1例:-両者の関連性の観点から
- 肝硬変におけるTIPSによるEndothelin-1の変化
- 巨大な食道壁外シャントを有する食道静脈瘤症例に対する選択的静脈瘤結紮併用硬化療法の試み